Treatment of these breast cancer cells with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), which is itself an estrogenic toxicant, altered the expression of enzymes responsible for the bio-activation of estrogen leading to DNA damage, PARP1 activation and DNA repair. The gene discussed is PARP1; the disease is breast carcinoma.